McKinsey Opioid Work Included Advising Distributors, Tribe Says
- Tribe’s suit says firm’s opioid role was wider than known
- McKinsey says none of this business focused on opioids
Photographer: Eric Baradat/AFP/Getty Images
This article is for subscribers only.
McKinsey & Co.’s role in assisting companies profiting from opioid-based painkillers was “far more extensive” than just advising makers of the highly addictive medicines, according to an Indian tribe’s newly filed lawsuit.
Besides advising manufacturers such as Johnson & Johnson and Endo International Plc, the consulting firm helped distributors and retailers including McKesson Corp. find ways to sell more opioids, the Oklahoma-based Cherokee Nation said in its suit.
McKinsey said the claim is incorrect.